ERIN HIMES: Open Payments
NPI 1043283252 · TOLLESBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 17 payments from 5 companies in 2025. Trend: 2023 $190 · 2024 $197 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $295 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: UBRELVY, QULIPTA, MAVYRET, BREZTRI, MOUNJARO, CAPLYTA, SHINGRIX, VRAYLAR.
Industry payments across KY — which companies pay providers there.
